Alopecia areata: current concepts

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Alopecia areata (AA) is a chronic autoimmune disorder causing relapsing, non-scarring hair loss.
• Disease presentation varies from patchy hair loss to extensive forms like alopecia totalis or universalis, impacting quality of life.
• Key pathogenic mechanisms include hair follicle immune privilege collapse, Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway activation, and genetic factors.

Purpose of the Study:

• To review current understanding of alopecia areata epidemiology, pathogenesis, diagnosis, and comorbidities.
• To summarize established and emerging therapeutic strategies for alopecia areata.
• To discuss future directions for improving patient outcomes in alopecia areata management.

Main Methods:

• Literature review of epidemiological data.
• Analysis of research on pathogenic mechanisms.
• Synthesis of current and emerging treatment options, including FDA-approved therapies.

Main Results:

• Alopecia areata involves complex immune dysregulation and genetic predisposition.
• Conventional treatments remain relevant for mild disease.
• Oral JAK inhibitors represent a significant advancement for severe alopecia areata, offering targeted systemic therapy.

Conclusions:

• Understanding the pathogenesis of alopecia areata has led to targeted therapies.
• Systemic JAK inhibitors provide a new treatment paradigm for severe alopecia areata.
• Continued research is crucial for optimizing patient outcomes and exploring novel therapeutic avenues.